The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma
2007

Matrix Metalloproteinase 9 in Nasal NK/T-Cell Lymphoma

Sample size: 45 publication Evidence: moderate

Author Information

Author(s): Sakata Koh-ichi, Someya Masanori, Omatsu Mutsuko, Asanuma Hiroko, Hasegawa Tadashi, Hareyama Masato, Himi Tetsuo

Primary Institution: Sapporo Medical University, School of Medicine

Hypothesis

The study investigates the expression of P-glycoprotein and MMP-9 in nasal NK/T-cell lymphoma and their relationship with clinical outcomes.

Conclusion

The strong expression of MMP-9 is characteristic of nasal NK/T cell lymphoma and may contribute to its tendency to metastasize.

Supporting Evidence

  • Overall 5-year survival rates for nasal NK/T cell lymphoma were 51%, compared to 84% for nasal non-NK/T cell lymphoma.
  • Distant involvement free 5-year survival rates for MMP-9 negative patients were 92%, while for MMP-9 positive patients it was 61%.
  • 16 of 19 patients with nasal NK/T cell lymphoma expressed MMP-9.

Takeaway

This study looked at a type of cancer called nasal NK/T-cell lymphoma and found that a protein called MMP-9 is very high in these patients, which might help the cancer spread.

Methodology

Immunohistochemical analysis of P-glycoprotein and MMP-9 expression in biopsy samples from patients with nasal NK/T-cell lymphoma and nasal non-NK/T-cell lymphoma.

Limitations

Results are based on univariate comparisons and should be viewed with caution.

Participant Demographics

20 patients with nasal NK/T cell lymphoma (10 men, 10 women) and 25 patients with nasal non-NK/T cell lymphoma (12 men, 13 women).

Statistical Information

P-Value

0.027

Statistical Significance

p = 0.027

Digital Object Identifier (DOI)

10.1186/1471-2407-7-229

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication